The independent source for health policy research, polling, and news.
941 - 960 of 1,288 Results
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico, and Erin Mershon of Stat News discuss a series of health policy court decisions on everything from prescription drug discounts to soda taxes. Plus, Rovner, interviews health care futurist and consultant Jeff Goldsmith.
Some state Medicaid programs are not paying for the procedures, and Medicareâs complicated payment rates have hospitals concerned that it will not cover all the costs.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the health politics of the latest Supreme Court pick, as well as the Trump administrationâs efforts to further undermine the Affordable Care Act. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
Other readers ask what can be done to challenge unexpected medical bills â whether the result of an emergency room visit or after a change in prescription drug coverage.
A survey of 49 states reveals that an estimated 144,000 inmates with hepatitis C, a curable but potentially fatal disease, canât get the expensive drugs they need to cure it.
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Anna Edney of Bloomberg News discuss the latest enrollment numbers for the Affordable Care Act, Medicaid work requirements in Kentucky and President Donald Trumpâs proposed government reorganization plan. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
The CEO of Comprehensive Pain Specialists was indicted in April. Now the group is closing clinics across several states.
Itâs getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drugâs high price and insurance company efforts to restrict the use of coupons that shield patients from it.
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
Dr. Mark McClellan joined Johnson & Johnsonâs board of directors after leaving the FDA, but the connection often isnât mentioned in research papers or public events.
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
As the opioid epidemic rages, a Johns Hopkins surgeon and researcher is leading an effort to curb overprescribing by offering procedure-specific guidelines to ensure that post-surgical patients leave the hospital with enough, but not too much, pain medication.
Purdue Pharma planned an extensive marketing campaign for the launch and promotion of the painkiller OxyContin. Here are Purdueâs internal budget documents from 1996 to 2002 â files released by the Florida attorney generalâs office â that detail the companyâs early strategy to sell and expand use of the drug.
An inside look at how Purdue Pharma pushed OxyContin despite risks of addiction and fatalities.
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
Sometimes a drug planâs copayment is higher than the cash price, and under a little-known federal rule, pharmacists have to tell Medicare beneficiaries that â but only if they ask.
More health plans are refusing to count the copayment assistance offered by drug makers as part of the patientsâ deductibles or out-of-pocket limits.
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Sarah Kliff of Vox and Alice Ollstein of Talking Points Memo discuss a proposed administration regulation that seeks to separate Planned Parenthood from federal family planning funds, the final congressional passage of legislation aimed at helping those with terminal illnesses obtain experimental medications, and new government reports on the uninsured and federal health spending. Also, Rovner interviews KHNâs Liz Szabo about the May âBill of the Month.â
© 2026 KFF